BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 8986740)

  • 1. The Influence of Interdisciplinary Work towards Advancing Knowledge on Human Liver Physiology.
    Delgado-Coello B; Navarro-Alvarez N; Mas-Oliva J
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte transplantation: Consider infusion before incision.
    Heath RD; Ertem F; Romana BS; Ibdah JA; Tahan V
    World J Transplant; 2017 Dec; 7(6):317-323. PubMed ID: 29312860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR Correction of a Homozygous Low-Density Lipoprotein Receptor Mutation in Familial Hypercholesterolemia Induced Pluripotent Stem Cells.
    Omer L; Hudson EA; Zheng S; Hoying JB; Shan Y; Boyd NL
    Hepatol Commun; 2017 Nov; 1(9):886-898. PubMed ID: 29130076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Transplantation for Liver Diseases.
    Jameson E
    Gastroenterology Res; 2008 Dec; 1(1):8-13. PubMed ID: 27994700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte transplantation in children with liver cell failure.
    Hamooda M
    Electron Physician; 2016 Oct; 8(10):3096-3101. PubMed ID: 27957309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental hepatocyte xenotransplantation--a comprehensive review of the literature.
    Zhou H; Liu H; Ezzelarab M; Schmelzer E; Wang Y; Gerlach J; Gridelli B; Cooper DK
    Xenotransplantation; 2015; 22(4):239-48. PubMed ID: 25950141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients.
    Hansel MC; Gramignoli R; Skvorak KJ; Dorko K; Marongiu F; Blake W; Davila J; Strom SC
    Curr Protoc Toxicol; 2014 Nov; 62():14.12.1-23. PubMed ID: 25378242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Menstrual blood-derived mesenchymal stem cells differentiate into functional hepatocyte-like cells.
    Mou XZ; Lin J; Chen JY; Li YF; Wu XX; Xiang BY; Li CY; Ma JM; Xiang C
    J Zhejiang Univ Sci B; 2013 Nov; 14(11):961-72. PubMed ID: 24190442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of human adipose tissue-derived multilineage progenitor cells reduces serum cholesterol in hyperlipidemic Watanabe rabbits.
    Okura H; Saga A; Fumimoto Y; Soeda M; Moriyama M; Moriyama H; Nagai K; Lee CM; Yamashita S; Ichinose A; Hayakawa T; Matsuyama A
    Tissue Eng Part C Methods; 2011 Feb; 17(2):145-54. PubMed ID: 20698754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to the successful treatment of liver disease by hepatocyte transplantation.
    Soltys KA; Soto-Gutiérrez A; Nagaya M; Baskin KM; Deutsch M; Ito R; Shneider BL; Squires R; Vockley J; Guha C; Roy-Chowdhury J; Strom SC; Platt JL; Fox IJ
    J Hepatol; 2010 Oct; 53(4):769-74. PubMed ID: 20667616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver cell transplantation for the treatment of inborn errors of metabolism.
    Meyburg J; Hoffmann GF
    J Inherit Metab Dis; 2008 Apr; 31(2):164-72. PubMed ID: 18392744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for atherosclerosis and atherosclerosis-related diseases.
    Pakkanen T; Ylä-Herttuala S
    Curr Atheroscler Rep; 1999 Sep; 1(2):123-30. PubMed ID: 11122701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Episomal segregation of the adenovirus enhancer sequence by conditional genome rearrangement abrogates late viral gene expression.
    Wang X; Zeng W; Murakawa M; Freeman MW; Seed B
    J Virol; 2000 Dec; 74(23):11296-303. PubMed ID: 11070029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study.
    Roger V; Balladur P; Honiger J; Baudrimont M; Delelo R; Robert A; Calmus Y; Capeau J; Nordlinger B
    Ann Surg; 1998 Jul; 228(1):1-7. PubMed ID: 9671059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation.
    Gunsalus JR; Brady DA; Coulter SM; Gray BM; Edge AS
    Nat Med; 1997 Jan; 3(1):48-53. PubMed ID: 8986740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypercholesterolemia in the Watanabe rabbit using allogeneic hepatocellular transplantation under a regeneration stimulus.
    Eguchi S; Rozga J; Lebow LT; Chen SC; Wang CC; Rosenthal R; Fogli L; Hewitt WR; Middleton Y; Demetriou AA
    Transplantation; 1996 Sep; 62(5):588-93. PubMed ID: 8830820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of apolipoprotein B secretion in hepatocytes from Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
    Tanaka M; Otani H; Yokode M; Kita T
    Atherosclerosis; 1995 Apr; 114(1):73-82. PubMed ID: 7605378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte transplantation for the low-density lipoprotein receptor-deficient state. A study in the Watanabe rabbit.
    Wiederkehr JC; Kondos GT; Pollak R
    Transplantation; 1990 Sep; 50(3):466-71. PubMed ID: 2144923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Watanabe heritable hyperlipidemic rabbit. Animal model for familial hypercholesterolemia.
    Havel RJ; Yamada N; Shames DM
    Arteriosclerosis; 1989; 9(1 Suppl):I33-8. PubMed ID: 2643428
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.